Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome
| Author | Seyed Reza Abtahi | en |
| Author | Parvin Zareian | en |
| Issued Date | 2015-08-31 | en |
| Abstract | Context: The irritable bowel syndrome (IBS) is a symptom-based gastrointestinal (GI) disease with the presence of symptoms such as abdominal pain and abnormal intestinal activities. It is a frequent GI problem encountered by physicians. The purpose of this paper was to review and assess some of the current and emerging pharmacological therapies for this syndrome. Evidence Acquisition: In the present study, data on the IBS were principally collected via Google Scholar and PubMed, followed by articles in journals and libraries. Results: The pathophysiology of the IBS has yet to be fully elucidated. Global medical attempts, including pharmacological therapy and herbal remedies, aim at curing and/or subsiding pain, flatulence, diarrhea, and constipation. Conclusions: There is a need for new drugs in the setting of pharmacological therapy for the IBS. A new medical approach should include both novel and traditional drugs in order to reach to a desirable outcome for patients and improve their quality of life. | en |
| DOI | https://doi.org/10.5812/jamm.30057 | en |
| Keyword | Diagnosis | en |
| Keyword | Irritable Bowel Syndrome | en |
| Keyword | Physiopathology | en |
| Keyword | Pharmacotherapy | en |
| Publisher | Brieflands | en |
| Title | Assessment of Consensus-Based Pharmacological Therapies in Irritable Bowel Syndrome | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- 20821-pdf.pdf
- Size:
- 408.71 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF